Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition.

Authors

• Teena Dhir
• Christopher W Schultz
• Aditi Jain
• Samantha Z Brown
• Alex Haber
• Austin Goetz
• Chunhua Xi
• Gloria H Su
• Liang Xu
• James Posey
• Wei Jiang
• Charles J Yeo
• Talia Golan
• Michael J Pishvaian
• Jonathan R Brody

Publication/Presentation Date

10-1-2019

Abstract

Mutation or promoter hypermethylation of

Volume

17

Issue

10

First Page

2029

Last Page

2041

ISSN

1557-3125

Published In/Presented At

Dhir, T., Schultz, C. W., Jain, A., Brown, S. Z., Haber, A., Goetz, A., Xi, C., Su, G. H., Xu, L., Posey, J., 3rd, Jiang, W., Yeo, C. J., Golan, T., Pishvaian, M. J., & Brody, J. R. (2019). Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. Molecular cancer research : MCR, 17(10), 2029–2041. https://doi.org/10.1158/1541-7786.MCR-19-0589

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

31383722

Department(s)

Administration and Leadership

Document Type

Article